Merck treatment for a type of uterus cancer fails trial
By Thomson ReutersMay 9, 2024 | 6:05 AM
(Reuters) – Merck said on Thursday its treatment for a type of uterus cancer did not meet the main goal of disease-free survival in a late-stage trial.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shounak Dasgupta)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at (615) 259-4567.
Comments